Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia.
Yassine HN, Arellanes IC, Mazmanian A, De La Cruz L, Martinez J, Contreras L, Kono N, Liu BS, Badie D, Bantugan MA, Grindon A, Urich T, D'Orazio L, Emmanuel BA, Chui HC, Mack WJ, Harrington MG, Braskie MN, Schneider LS.
Yassine HN, et al. Among authors: mack wj.
J Prev Alzheimers Dis. 2023;10(4):810-820. doi: 10.14283/jpad.2023.77.
J Prev Alzheimers Dis. 2023.
PMID: 37874103
Clinical Trial.